Clinical trials recruiting for Breast Cancer Stage III

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of Language Interpretation Solutions for People With Breast Cancer
  NCT06721065 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
  NCT07225309 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
  NCT05288777 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Capecitabine in ER+/HER2-negative Breast Cancer
  NCT07631052 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
  NCT06802172 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
  NCT05877859 · Phase: Not specified · Ages: 18 Years and older · Sex: Female · 1 location
• Evaluation of Radiobiological Effects in Skin Toxicities for Breast Cancer Patients With Pencil Beam Scanning Proton Therapy
  NCT06006806 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location
• Evaluation of the Efficacy of Biobran (Rice Bran Arabinoxylan) in Supporting Breast Cancer Chemotherapy
  NCT07503496 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 65 Years · Sex: Female · 2 locations
• Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer
  NCT06727773 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Optimizing Surgical Decisions in Young Adults With Breast Cancer
  NCT06275126 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 44 Years · Sex: Female · 4 locations
• Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
  NCT06806930 · Phase: Phase 2 · Ages: 21 Years and older · Sex: All (male and female) · 1 location
• Radiotherapy Dose Adaptation Based on Tumor Biology in Patients With cN2b-N3 Breast Cancer
  NCT05896865 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years and older · Sex: Female · 1 location
• Virtual Rehabilitation for Cancer Survivors
  NCT05898789 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations

Related conditions

Trials recruiting for Breast Cancer Stage III often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Breast Cancer Stage III trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.